Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor
- 1.2k Downloads
Podocytes are insulin-responsive cells of the glomerular filtration barrier and are key in preventing albuminuria, a hallmark feature of diabetic nephropathy. While there is evidence that a loss of insulin signalling to podocytes is detrimental, the molecular mechanisms underpinning the development of podocyte insulin resistance in diabetes remain unclear. Thus, we aimed to further investigate podocyte insulin responses early in the context of diabetic nephropathy.
Conditionally immortalised human and mouse podocyte cell lines and glomeruli isolated from db/db DBA/2J mice were studied. Podocyte insulin responses were investigated with western blotting, cellular glucose uptake assays and automated fluorescent imaging of the actin cytoskeleton. Quantitative (q)RT-PCR was employed to investigate changes in mRNA. Human cell lines stably overproducing the insulin receptor (IR) and nephrin were also generated, using lentiviral constructs.
Podocytes exposed to a diabetic environment (high glucose, high insulin and the proinflammatory cytokines TNF-α and IL-6) become insulin resistant with respect to glucose uptake and activation of phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signalling. These podocytes lose expression of the IR as a direct consequence of prolonged exposure to high insulin concentrations, which causes an increase in IR protein degradation via a proteasome-dependent and bafilomycin-sensitive pathway. Reintroducing the IR into insulin-resistant human podocytes rescues upstream phosphorylation events, but not glucose uptake. Stable expression of nephrin is also required for the insulin-stimulated glucose uptake response in podocytes and for efficient insulin-stimulated remodelling of the actin cytoskeleton.
Together, these results suggest that IR degradation, caused by high levels of insulin, drives early podocyte insulin resistance, and that both the IR and nephrin are required for full insulin sensitivity of this cell. This could be highly relevant for the development of nephropathy in individuals with type 2 diabetes, who are commonly hyperinsulinaemic in the early phases of their disease.
KeywordsAlbuminuria Diabetic nephropathy Genetic background Insulin resistance Kidney injury
Mitogen-activated protein kinase
Mechanistic target of rapamycin
Reactive oxygen species
Wild-type cells producing insulin receptor and nephrin
Wild-type cells producing nephrin
Vascular endothelial growth factor
Diabetic nephropathy, in which albuminuria is an early manifestation, occurs in approximately one third of diabetic individuals and is the leading cause of end-stage renal failure worldwide . It is well recognised that insulin resistance plays a major role in the pathogenesis of both type 1 and type 2 diabetes [2, 3], including a role in the development of renal complications. Interestingly, in addition to being associated with albuminuria and nephropathy in both type 1 [4, 5] and type 2  diabetes, insulin resistance is also associated with the development of albuminuria in non-diabetic individuals . Renal disease is also common among people with severe forms of genetic insulin resistance .
A range of circulating factors are dysregulated early in the development of systemic insulin resistance, as either a cause or a consequence of disrupted cellular insulin signalling. Among these factors, elevated inflammatory cytokines, hyperglycaemia and hyperinsulinaemia are particularly prominent . Although the negative regulation of insulin signalling is relatively well characterised in classical insulin-responsive tissues, such as skeletal muscle and liver, the impairment of insulin action does not occur uniformly throughout all insulin-responsive tissues, and the effects of factors associated with insulin resistance are often tissue-specific .
Podocytes are specialised epithelial cells lining the urinary side of the glomerular filtration barrier in the kidney, essential in the maintenance of glomerular function. Podocyte loss or disturbance is linked to the development of albuminuria and occurs early in the progression of diabetic nephropathy [11, 12, 13, 14].
We previously demonstrated that podocytes are insulin-responsive cells in vitro , and the specific deletion of the podocyte insulin receptor (IR) in vivo disrupts glomerular function, causing features reminiscent of diabetic nephropathy, independent of hyperglycaemia . Furthermore, a podocyte-specific reduction in IR production has been found to exacerbate albuminuria in a mouse model of diabetic nephropathy , further highlighting the importance of podocyte IR signalling in disease.
There is also increasing evidence that podocyte insulin responses may be negatively regulated in situations of systemic insulin resistance [18, 19]. In particular, the finding that podocytes isolated from db/db mice display reduced insulin-stimulated Akt phosphorylation may suggest that circulating factors, associated with type 2 diabetes, have the capacity to disrupt podocyte insulin responses early in the course of glomerular disease . Despite this, relatively little is still known about the specific factors that regulate podocyte insulin responses.
This study aimed to investigate how factors associated with systemic insulin resistance influence podocyte insulin signalling and, consequently, the development of renal disease in situations of insulin resistance, including diabetic nephropathy.
All animal experiments and procedures were approved by the UK Home Office in accordance with the Animals (Scientific Procedures) Act 1986, and the Guide for the Care and Use of Laboratory Animals was followed during experiments. Heterozygous db/wt DBA/2J (D2.BKS(D)-Lepr db /J) mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Female and male db/db mice were bred in house, as described . Glomeruli were isolated after perfusion with dynabeads (Thermo Fisher, Paisley, UK). Further details are available in the electronic supplementary material (ESM).
Generation of podocyte cell lines from db/db and wild-type mice
Podocytes were isolated from perfused glomeruli from a male db/db DBA/2J and male wild-type (WT) DBA/2J littermate control mouse at 12 weeks of age. These podocytes were conditionally immortalised with temperature-sensitive SV40 transfection as previously described [22, 23].
Conditionally immortalised human  and mouse  podocytes were maintained in RPMI-1640 containing l-glutamine and NaHCO3, supplemented with 10% FBS (Sigma Aldrich, Gillingham, UK). Cells were studied after 12–14 days differentiation at 37°C and were free of Mycoplasma infection.
To mimic a diabetic environment in vitro, podocytes were grown in the presence of 100 nmol/l insulin (Tocris, Bristol, UK), 25 mmol/l glucose (Sigma), 1 ng/ml TNF-α and 1 ng/ml IL-6 (R&D systems, Abingdon, UK). d-Mannitol (Sigma) was used as a control for osmotic pressure in these assays. For initial chronic insulin exposure, podocytes were incubated with insulin at 10 nmol/l and 100 nmol/l for 10 days. Although supraphysiological (as physiological hyperinsulinaemia is typically within the range 1000–2000 pmol/l, occurring over an extended period of months or years), this is consistent with numerous in vitro studies of other cell types [25, 26, 27, 28, 29, 30]. For short-term insulin stimulation, culture medium was replaced with serum- and insulin-free RPMI-1640 for 2–4 h, and podocytes were re-challenged with insulin at 10 or 100 nmol/l for 10 min. For inhibition of proteasomal and lysosomal degradation, podocytes were treated with 10 μmol/l MG-132 (Sigma) or 50 nmol/l bafilomycin (Tocris), respectively, for 8 h.
Lentiviral transfection of podocytes
Human IR (NM_000208.2) was subcloned into pLenti-TetCMV(IR)-Rsv(RFP-Bsd) expression vector (Gentarget, San Diego, CA, USA). The human nephrin expression plasmid (pWPXL-Nephrin-FLAG) was a gift from R. Lennon (University of Manchester). Expression vectors were transfected into Lenti-X 293T cells (Clontech/Takara Bio Europe SAS, Saint-Germain-en-Laye, France), together with packaging vectors pMD.2G (Addgene no. 12259) and psPAX2 (Addgene no. 12260), both gifts from D. Trono (École polytechnique fédérale de Lausanne), as previously reported . Lentiviral particles were purified from the cell supernatant fraction, and immortalised podocytes were transduced overnight in the presence of polybrene. IR-containing podocytes were selected using blasticidin.
Glucose uptake assays
Insulin-stimulated glucose uptake into podocytes was measured as previously described . Briefly, cells were serum-starved before incubation with a modified KRP solution (see ESM Methods) for 15 min at 37°C. After appropriate stimulation, [3H]2-deoxy-d-glucose (Perkin Elmer, Coventry, UK) was added at 37 kBq/ml for 5 min. Solubilised cell suspensions were collected, and radioactivity was measured in dpm using a multi-purpose scintillator counter (Beckman Coulter, High Wycombe, UK). Each condition was performed in duplicate or triplicate.
Total RNA was isolated using TRIzol Reagent (Invitrogen/Thermo Fisher), and cDNA was synthesised using a high-capacity RNA-cDNA kit (Applied Biosystems/Thermo Fisher). Quantitative (q)RT-PCR was performed using SYBR green (Sigma) in an Applied Biosystems StepOnePlus system and mRNA normalised to β-actin. Primer sequences are listed in ESM Methods.
Western blotting and antibodies
Total protein lysates were extracted using RIPA lysis buffer (Sigma), resolved on 7.5–10% SDS-polyacrylamide gels and blotted onto nitrocellulose membranes. Membranes were incubated in primary antibodies overnight at 4°C, before washing and incubation with the appropriate HRP-conjugated secondary antibody (Sigma) at a 1:10,000 dilution. Immunoreactive bands were visualised using Clarity ECL Western Blotting Substrate (Bio-Rad, Hemel Hempstead, UK) on a GE AI600 imager and quantified using ImageJ (NIH, https://imagej.nih.gov/ij/). Primary antibodies are listed in ESM Methods.
For immunoprecipitation studies, 5 μg of anti-IRβ (C-19)-AC or Rabbit IgG-AC (Santa Cruz, Dallas, TX, USA) was added directly to cell lysates and incubated overnight at 4°C, under constant rotation. Immune complexes were pelleted at 10,000 g for 30 s and washed in lysis buffer. Immune complexes were eluted at 70°C for 10 min. Immunoprecipitation samples were resolved on 7.5% SDS-PAGE gels before western blotting.
Semi-automated immunofluorescent imaging and analysis
Cells were grown in 96-well plates (Greiner, Stonehouse, UK), stimulated as indicated before fixation and immunostaining. Image acquisition was automated using an IN Cell Analyzer (GE Healthcare, Amersham, UK) imaging platform, and quantification was performed using IN Cell Analyzer work station 3.5 software. Three technical replicates were performed within each experiment, with four fields of view per well, yielding data for around 2000 cells per condition, per experiment. Additional details can be found in ESM Methods.
Data are presented as means ± SEM unless otherwise stated. Statistical analysis was performed using GraphPad Prism (GraphPad Software, La Jolla, CA, USA). Statistical significance was calculated with one-way ANOVA with Tukey’s multiple comparison post hoc analysis, or unpaired two-tailed t tests and taken as p < 0.05.
Culturing insulin-sensitive podocytes in a diabetic environment induces cellular insulin resistance
We have recently shown that db/db mice on a DBA2/J background develop albuminuric renal disease in correlation with the level of systemic insulin resistance . Glomeruli isolated from these mice demonstrated a trend towards a reduction in IR levels between 8 and 12 weeks of age (as diabetes and albuminuria progresses) (Fig. 2d). To determine podocyte IR production in this model, we isolated podocytes from male db/db mice and male WT littermate control animals at 12 weeks of age and generated conditionally immortalised cell lines. Interestingly, podocytes isolated from db/db animals had a significantly lower level of IR protein than podocytes isolated from WT littermate control mice (Fig. 2e). Primary podocytes isolated from db/db mice also showed reduced IR production when compared with age- and sex-matched control mice (ESM Fig. 1).
Thus, factors associated with systemic insulin resistance modulate podocyte IR levels, attenuating insulin-stimulated phosphorylation cascades.
Chronic insulin exposure alone is responsible for podocyte IR loss and is sufficient to attenuate podocyte insulin signalling
Increased IR degradation is responsible for insulin-induced IR loss in podocytes
The IR also exists as two isoforms as a consequence of the differential splicing of exon 11 , and the relative abundance of IR-A/B has been linked to hyperinsulinaemia . As podocytes produce both IR isoforms , we quantified the relative abundance of Ir-A/B mRNA in podocytes using isoform-specific primers . Although a significantly higher proportion of Ir-A mRNA (than that encoding Ir-B) was observed in podocytes, there was no significant effect of chronic insulin exposure on the relative abundance of either isoform (Fig. 6c–f).
Inhibition of proteasomal degradation in podocytes by an 8 h incubation with the 26S proteasome inhibitor MG132 (confirmed by an increase in ubiquitinated proteins) also delayed insulin-induced IR loss (Fig. 7b). In addition, we found evidence of IR ubiquitination. A small increase in ubiquitination was observed in IRβ immunoprecipitates where mouse podocytes were treated with both insulin and MG132. In mouse podocytes overproducing IR, we observed strong ubiquitin signals, confirming these results (ESM Fig. 2).
We saw no additional effect where proteasome and lysosome inhibitors were used in combination (Fig. 7c).
As mechanistic target of rapamycin (mTOR) is activated by insulin signalling , and may also regulate autophagy , we also investigated whether mTOR signalling had any involvement in insulin-induced insulin resistance in podocytes. Inhibition of mTOR with rapamycin had no significant effect on IR levels (Fig. 7d).
Restoring insulin signalling in insulin-resistant human podocytes requires stable expression of both IR and nephrin
Human podocytes used in previous studies [15, 39, 40] have become ‘naturally’ insulin resistant as a consequence of continuous and historical cell culture conditions, whereby cell culture media were supplemented with insulin at concentrations in excess of 200 nmol/l . To determine whether IR loss was a primary cause of insulin resistance in these cells, human podocytes (WT) were stably transfected with the human IR using lentivirus (WT-IR podocytes).
As we have previously demonstrated that nephrin is necessary for insulin-stimulated glucose uptake in podocytes [39, 40], and nephrin loss is also evident in diabetic environments [41, 42, 43], the effect of stable nephrin overproduction in insulin-resistant human podocytes was investigated. As shown in Fig. 8d, podocytes stably producing both IR and nephrin (WT-IR-Neph) retained their insulin-stimulated phosphorylation of Akt. In addition, a significant increase in glucose uptake into WT-IR-Neph podocytes was observed (Fig. 8e). Overproduction of nephrin alone did not rescue insulin-stimulated Akt phosphorylation or glucose uptake (Fig. 8d, f).
As nephrin has a key role in regulating the podocyte actin cytoskeleton , and the insulin-stimulated trafficking of glucose transporters (in GLUT storage vesicles) to the plasma membrane relies on the actin cytoskeleton , we hypothesised that the requirement of nephrin for glucose uptake in podocytes might also be related to actin modulation. As such, we next investigated insulin-stimulated actin reorganisation in these cells, using automated microscopy and image analysis. Cells positive for actin remodelling were defined as those with a loss of defined (central) F-actin structures, as this is generally considered to indicate reorganisation .
Hyperinsulinaemia is a major metabolic abnormality associated with systemic insulin resistance . In addition to the association between insulin resistance and albuminuria [4, 5, 6], hyperinsulinaemia per se is related to albuminuria in type 2 diabetes  and in type 1 diabetes, where nephropathy is associated with higher therapeutic doses of insulin .
At a cellular level, hyperinsulinaemia may exacerbate insulin resistance, disrupting insulin action at several points within the signalling cascade, in a cell-specific manner . At the level of the IR, chronic insulin stimulation can promote receptor downregulation in classically insulin-responsive tissues such as skeletal muscle and liver [26, 27, 28], as well as other cell types including pancreatic alpha cells  and cultured neurones [29, 30].
The present study demonstrates, for the first time, that the glomerular podocyte is also subject to insulin-induced IR degradation, resulting in an attenuation of insulin signalling responses. Given that we  and others  have shown the podocyte-specific knockdown of the IR induces albuminuria and glomerular disease, it is reasonable to predict that this insulin-induced IR loss could further contribute to renal disease in settings of diabetes and insulin resistance.
Mechanistically, we demonstrated that insulin-induced IR degradation occurs via a proteasome-dependent and bafilomycin-sensitive pathway. In contrast to studies performed in other cell systems [26, 27], we found that chronic insulin stimulation of podocytes had no significant effect on IR mRNA. We did, however, demonstrate that the relative abundance of IR-A mRNA is greater than that of IR-B in podocytes. As IR-A is the isoform thought to be responsible for IR-mediated IGF-II signalling, this may be of relevance in IGF-II signalling to this cell [32, 51].
Although we found that the insulin-induced degradation of IRS-1  and IRS-2  observed in other cell systems does not occur in podocytes, in agreement with previous studies performed in a rat model of streptozotocin-induced diabetes and glomerular endothelial cells , we detected a reduction in podocyte IRS-1 content as a consequence of high glucose exposure. Our finding that there was no significant reduction in the insulin-stimulated phosphorylation of Akt or glucose uptake under these conditions is in line with our recent studies suggesting that IRS-2, as opposed to IRS-1, is the principal isoform facilitating podocyte insulin signal transduction to stimulate Akt phosphorylation and glucose uptake . However, this does not eliminate the possibility that IRS-1 could mediate other insulin responses in podocytes, or selectively modulate individual Akt isoforms.
We also demonstrate that while initial insulin signalling events leading to Akt phosphorylation in podocytes do not require nephrin, the stable expression of both IR and nephrin is necessary to mediate insulin-stimulated glucose transport downstream of Akt. Interestingly, it is well documented that nephrin production is also lost early in human diabetic nephropathy  and experimental models of diabetes [41, 42].
We hypothesised, given the importance of actin regulation in the insulin-stimulated glucose uptake response , that the requirement for nephrin in glucose uptake might also be linked to the role of nephrin in modulating the podocyte actin cytoskeleton , a process that is closely related to podocyte function at the filtration barrier. As such, we investigated how insulin-stimulated actin remodelling was affected in our model systems, and found that podocytes with stable over expression of both nephrin and IR were more responsive to insulin in terms of F-actin remodelling, compared with podocytes overexpressing IR alone.
Others have shown nephrin may also interact with the IR , investigating whether nephrin also affects localisation of IR, or indeed IR binding to downstream targets, may be of interest. Whether this may also be linked to the ability of nephrin to preferentially phosphorylate selective Akt isoforms remains to be investigated, as Akt2 has been suggested to differentially modulate the podocyte actin cytoskeleton in comparison to Akt1 . In addition, we found that the actin remodelling downstream of insulin was blocked following exposure of these podocytes to a diabetic environment, suggesting that these cells may still become insulin resistant following further challenge with a diabetic environment.
Aside from enhancing cellular glucose uptake and promoting the reorganisation of F-actin structures, podocyte IR signalling has the capacity to regulate vascular endothelial growth factor (VEGF)-A production , cell viability , reactive oxygen species (ROS) production and autophagy , all of which are key in maintaining glomerular filtration and are dysregulated in diabetes. Recently, the importance of IR signalling in the adaptation of podocytes to endoplasmic reticulum stress and the unfolded protein response in diabetes has further highlighted the physiological importance of this pathway in disease responses . A further study has also linked podocyte IR signalling to mitochondrial function, which may be related to the modulation of mTOR signalling , which is also crucial in the maintenance of podocytes in health and disease.
In summary, this study demonstrates that podocytes exposed to a diabetic environment become insulin resistant. This response is, at least in part, mediated by chronic exposure to elevated insulin levels promoting podocyte IR degradation. Moreover, we demonstrated that the expression of both IR and nephrin is required for full podocyte insulin sensitivity. Thus, hyperinsulinaemia may further accentuate the progression of renal disease in states of insulin resistance, including diabetic nephropathy, and the maintenance of podocyte nephrin and IR expression and function in these settings may be therapeutically beneficial.
We thank K. Garner (University of Bristol, UK), who advised on IN Cell data analysis, and L. Farmer (University of Bristol, UK), who assisted with lentivirus work.
All data generated or analysed during this study are included in this published article (and its supplementary information files). Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
This study was supported by grants from Kidney Research UK, which funded ACL with a PhD Studentship (ST7/2011) and latterly a project grant to RJMC (RP26/2014), and the MRC, which funds RJMC with a Senior Research Fellowship (MR/K010492/1). RR is supported by a Kidney Research UK John Feehally-Stoneygate award (JR-S/RP/2014/4).
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.
ACL, GIW and RJMC designed the experiments and wrote the manuscript. ACL performed and supervised the experiments. JAH and FB performed and oversaw the animal experiments. VMSB made IR lentivirus and IR-overexpressing cells. LN conditionally immortalised the podocyte cell lines. MVO performed studies on whole mouse glomeruli. LG and GMEP performed initial in vitro studies. HH and RL made the nephrin construct, and RR made the nephrin lentivirus. All authors contributed to the drafting of the manuscript and approved the final version. RJMC is the guarantor of this work.
- 18.Lay A, Coward RJ (2014) Recent advances in our understanding of insulin signalling to the podocyte. Nephrol Dial Transplant 29:1127–1133Google Scholar
- 24.Saleem MA, O'Hare MJ, Reiser J et al (2002) A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13:630–638Google Scholar
- 41.Morito N, Yoh K, Ojima M et al (2014) Overexpression of Mafb in podocytes protects against diabetic nephropathy. J Am Soc Nephrol 25:2546–2557Google Scholar
- 54.Santamaria B, Marquez E, Lay A et al (1853) IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes. Biochim Biophys Acta 2015:3224–3234Google Scholar
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.